Literature DB >> 11309482

Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity.

P O Flores-Villanueva1, E J Yunis, J C Delgado, E Vittinghoff, S Buchbinder, J Y Leung, A M Uglialoro, O P Clavijo, E S Rosenberg, S A Kalams, J D Braun, S L Boswell, B D Walker, A E Goldfeld.   

Abstract

Certain HLA-B antigens have been associated with lack of progression to AIDS. HLA-B alleles can be divided into two mutually exclusive groups based on the expression of the molecular epitopes HLA-Bw4 and HLA-Bw6. Notably, in addition to its role in presenting viral peptides for immune recognition, the HLA-Bw4, but not HLA-Bw6, motif functions as a ligand for a natural killer cell inhibitory receptor (KIR). Here, we show that profound suppression of HIV-1 viremia is significantly associated with homozygosity for HLA-B alleles that share the HLA-Bw4 epitope. Furthermore, homozygosity for HLA-Bw4 alleles was also significantly associated with the ability to remain AIDS free and to maintain a normal CD4 T cell count in a second cohort of HIV-1-infected individuals with well defined dates of seroconversion. This association was independent of the presence of a mutation in CC chemokine receptor 5 (CCR5) associated with resistance to HIV-1 infection, and it was independent of the presence of HLA alleles that could potentially confound the results. We conclude that homozygosity for HLA-Bw4-bearing B alleles is associated with a significant advantage and that the HLA-Bw4 motif is important in AIDS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11309482      PMCID: PMC33177          DOI: 10.1073/pnas.071548198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells.

Authors:  G B Cohen; R T Gandhi; D M Davis; O Mandelboim; B K Chen; J L Strominger; D Baltimore
Journal:  Immunity       Date:  1999-06       Impact factor: 31.745

2.  New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS.

Authors:  H Hendel; S Caillat-Zucman; H Lebuanec; M Carrington; S O'Brien; J M Andrieu; F Schächter; D Zagury; J Rappaport; C Winkler; G W Nelson; J F Zagury
Journal:  J Immunol       Date:  1999-06-01       Impact factor: 5.422

3.  Control of HIV despite the discontinuation of antiretroviral therapy.

Authors:  J Lisziewicz; E Rosenberg; J Lieberman; H Jessen; L Lopalco; R Siliciano; B Walker; F Lori
Journal:  N Engl J Med       Date:  1999-05-27       Impact factor: 91.245

4.  Typing of HLA-B*15 alleles using sequence-specific primers.

Authors:  N Yu; M Ohashi; S Alosco; M Salazar; K Cao; M Fernandez Vina; E J Yunis
Journal:  Tissue Antigens       Date:  1998-09

5.  Long-term survival after infection with human immunodeficiency virus type 1 (HIV-1) among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1995.

Authors:  B A Koblin; B H van Benthem; S P Buchbinder; L Ren; E Vittinghoff; C E Stevens; R A Coutinho; G J van Griensven
Journal:  Am J Epidemiol       Date:  1999-11-15       Impact factor: 4.897

6.  Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.

Authors:  S A Kalams; S P Buchbinder; E S Rosenberg; J M Billingsley; D S Colbert; N G Jones; A K Shea; A K Trocha; B D Walker
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

8.  HLA-Cw alleles associated with HLA extended haplotypes and C2 deficiency.

Authors:  O P Clavijo; J C Delgado; Z L Awdeh; D Fici; D Turbay; C A Alper; L Truedsson; E J Yunis
Journal:  Tissue Antigens       Date:  1998-09

9.  Natural killer cell-mediated lysis of autologous cells modified by gene therapy.

Authors:  C Liberatore; M Capanni; N Albi; I Volpi; E Urbani; L Ruggeri; A Mencarelli; F Grignani; A Velardi
Journal:  J Exp Med       Date:  1999-06-21       Impact factor: 14.307

10.  Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

Authors:  X Jin; D E Bauer; S E Tuttleton; S Lewin; A Gettie; J Blanchard; C E Irwin; J T Safrit; J Mittler; L Weinberger; L G Kostrikis; L Zhang; A S Perelson; D D Ho
Journal:  J Exp Med       Date:  1999-03-15       Impact factor: 14.307

View more
  100 in total

1.  HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.

Authors:  Zaheed Husain; Edward Levitan; Charles E Larsen; Nadeem M Mirza; Souhad Younes; Edmond J Yunis; Chester A Alper; Devendra P Dubey
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

Review 2.  Host genetic factors in susceptibility to HIV-1 infection and progression to AIDS.

Authors:  Koushik Chatterjee
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

3.  HLA B*5701-positive long-term nonprogressors/elite controllers are not distinguished from progressors by the clonal composition of HIV-specific CD8+ T cells.

Authors:  Daniel Mendoza; Cassandra Royce; Laura E Ruff; David R Ambrozak; Máire F Quigley; Thurston Dang; Vanessa Venturi; David A Price; Daniel C Douek; Stephen A Migueles; Mark Connors
Journal:  J Virol       Date:  2012-01-25       Impact factor: 5.103

4.  Natural killer cell immunoglobulin-like receptors (KIR) genotypes in two arab populations: will KIR become a genetic landmark between nations?

Authors:  Roni Rayes; Ali Bazarbachi; Georges Khazen; Amira Sabbagh; Ghazi Zaatari; Rami Mahfouz
Journal:  Mol Biol Rep       Date:  2007-03-26       Impact factor: 2.316

5.  Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease.

Authors:  Sandra M Mueller; Birgit Schaetz; Kathrin Eismann; Silke Bergmann; Michael Bauerle; Matthias Schmitt-Haendle; Hauke Walter; Barbara Schmidt; Klaus Korn; Heinrich Sticht; Bernd Spriewald; Ellen G Harrer; Thomas Harrer
Journal:  J Virol       Date:  2007-01-03       Impact factor: 5.103

Review 6.  Evolutionary struggles between NK cells and viruses.

Authors:  Lewis L Lanier
Journal:  Nat Rev Immunol       Date:  2008-03-14       Impact factor: 53.106

7.  The -1030/-862-linked TNF promoter single-nucleotide polymorphisms are associated with the inability to control HIV-1 viremia.

Authors:  Julio C Delgado; Jessica Y Leung; Andres Baena; Olga P Clavijo; Eric Vittinghoff; Susan Buchbinder; Steven Wolinsky; Marilynn Addo; Bruce D Walker; Edmond J Yunis; Anne E Goldfeld
Journal:  Immunogenetics       Date:  2003-09-27       Impact factor: 2.846

8.  Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.

Authors:  Thomas van Stigt Thans; Janet I Akko; Annika Niehrs; Wilfredo F Garcia-Beltran; Laura Richert; Christina M Stürzel; Christopher T Ford; Hui Li; Christina Ochsenbauer; John C Kappes; Beatrice H Hahn; Frank Kirchhoff; Glòria Martrus; Daniel Sauter; Marcus Altfeld; Angelique Hölzemer
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

Review 9.  Resolution of immune activation defines nonpathogenic SIV infection.

Authors:  Olivier Manches; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

10.  The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection.

Authors:  Stephen A. Migueles; Mark Connors
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.